IL2 and neoplasm: Their tumor-permissive effect is achieved either by restraining the proliferation of tumor-specific effector cells or by limiting the secretion of IL-2 and IFN-γ owing to the expression of CTLA-4, glucocorticoid-induced tumor necrosis factor receptor (GITR), and Foxp3 [173,174,175].